Status:
COMPLETED
The Organ Protection of Astragalus in Subjects With Metabolic Syndrome
Lead Sponsor:
LanZhou University
Conditions:
Metabolic Syndrome
Eligibility:
All Genders
18-80 years
Phase:
PHASE3
Brief Summary
Metabolic syndrome have the damages on tissues and organs in heart、kindey and vessels. In this study, prospective randomized, controlled, parallel designed ,different doses of Astragalus Mongolia, Gan...
Eligibility Criteria
Inclusion
- age 18 years or older, meet the diagnostic criteria of MS
- non-allergic with the astragalus
- agree to conduct clinical trials and those who signed the informed consent
Exclusion
- patients with resistant hypertension
- renal disease requiring dialysis
- heart failure NYHA ⅢorⅣ;
- complications of diabetes
- arteritis
- cancer
- thyroid disease
- unstable coronary heart disease
- peripheral vascular disease
- acute cerebral vascular disease11.pregnancy、 planned pregnancy
- patients with anti-oxidants
- acute infection
- other organic dysfunction, such as the liver, respiratory system, blood system, and other rheumatic diseases.
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
210 Patients enrolled
Trial Details
Trial ID
NCT01847807
Start Date
January 1 2011
Last Update
October 9 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lanzhou University Second Hospital
Lanzhou, Gansu, China, 730030